Lung cancer is the leading cause of cancer-related deaths worldwide. Non-small cell lung
cancer (NSCLC) accounts for approximately 80% of all lung cancers, and most NSCLC is …

Simple Summary Differences in epidemiological and clinical patterns of lung
adenocarcinoma have been described between male and female patients. Our study aimed …

Background Lung cancer causes approximately 25% of all cancer deaths. Despite its
relevance, few studies have analyzed differences by sex at the time of diagnosis in terms of …

Lung cancer is the fourth most common cancer diagnosed in Spain in both sexes, after
colorectal, prostate, and breast cancers (Table 1), with a 5-year survival of 12.7% in men …

Background The survival of patients with lung cancer has substantially increased in the last
decade by about 15%. This increase is, basically, due to targeted therapies available for …

Background Lung cancer is the third most frequent tumor and the main cause of death by
tumor in Spain. Although the incidence and mortality are still significantly higher in men than …

Purpose This study aimed to investigate the differences in characteristics, clinical stages,
treatment modalities, and survival outcomes in patients with non‐small‐cell lung cancer …

Background Metastatic non‐small cell lung cancer (NSCLC) is mostly seen in older patients
and is associated with poor prognosis. There is no reliable method to predict the prognosis …

Background Whether sex is an independent prognostic factor in lung cancer survival is the
subject of ongoing debate. Both large national registries and single hospital studies have …

Background: This study aims to assess the sex disparities in clinical characteristics and
synchronous distant metastasis occurrence at diagnosis, as well as the subsequent …